EZH2 and lung carcinoma: PRC2 comprises four main subunits: EED, SUZ12, RBAP46/47, and EZH2, with EZH2 acting as the catalytic subunit which has been implicated in metastasis, particularly in breast, prostate, and lung cancers [87–89].